Belluscura Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • PIPE
  • (Announced)

  • Latest Deal Amount
  • $4.69M

  • Investors
  • 2

Belluscura General Information

Description

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 15 Fetter Lane
  • London EC1M 4JN
  • England, United Kingdom
+44 0877
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Vertical(s)
Corporate Office
  • 15 Fetter Lane
  • London EC1M 4JN
  • England, United Kingdom
+44 0877

Belluscura Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belluscura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. PIPE 06-Feb-2025 $4.69M Announced Generating Revenue
14. 2PO 11-Feb-2025 Completed Generating Revenue
13. PIPE 02-Jul-2024 Completed Generating Revenue
12. PIPE 31-May-2023 Completed Generating Revenue
11. PIPE 10-Feb-2023 Completed Generating Revenue
10. IPO 28-May-2021 Completed Generating Revenue
9. Secondary Transaction - Private 01-Mar-2021 Completed Generating Revenue
8. Early Stage VC 10-Jun-2020 Completed Generating Revenue
7. Early Stage VC 31-Oct-2019 $2.91M $10.2M Completed Generating Revenue
6. Early Stage VC 04-Dec-2018 $3.53M $7.26M Completed Generating Revenue
To view Belluscura’s complete valuation and funding history, request access »

Belluscura Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,117,918 $0.012352 $0.62 $0.62 $0.62 2.56%
Ordinary 2,500,000 $0.012352 $0.52 $0.52 $0.52 5.73%
To view Belluscura’s complete cap table history, request access »

Belluscura Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen
Therapeutic Devices
London, United Kingdom
22 As of 2025

Beverly, MA
 

Ball Ground, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Belluscura Competitors (3)

One of Belluscura’s 3 competitors is Inogen, a Formerly VC-backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inogen Formerly VC-backed Beverly, MA
CAIRE (Georgia) Formerly VC-backed Ball Ground, GA
Philips Corporation Amsterdam, Netherlands
You’re viewing 3 of 3 competitors. Get the full list »

Belluscura Patents

Belluscura Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4117758-B1 Oxygen delivery system for the treatment of chronic obstructive pulmonary disease Active 13-Mar-2020
AU-2021233029-A1 Portable ventilator Active 13-Mar-2020
AU-2021233029-B2 Portable ventilator Inactive 13-Mar-2020
EP-4117758-A1 Portable ventilator Active 13-Mar-2020
EP-4117758-A4 Portable ventilator Active 13-Mar-2020 A61M16/0672
To view Belluscura’s complete patent history, request access »

Belluscura Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Belluscura Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tekcapital Venture Capital Minority
Cardiff University University Minority
To view Belluscura’s complete investors history, request access »

Belluscura Acquisitions (3)

Belluscura’s most recent deal was a Merger/Acquisition with TMT Acquisition (Special Purpose Acquisition Company (SPAC)) for . The deal was made on 08-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TMT Acquisition (Special Purpose Acquisition Company (SPAC)) 08-Mar-2024 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
Nanotether Discovery Science 25-Apr-2017 Merger/Acquisition Discovery Tools (Healthcare)
Stryker Corporation (Medical Devices) 13-Apr-2016 Merger/Acquisition Other Commercial Services
To view Belluscura’s complete acquisitions history, request access »

Belluscura ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Belluscura’s complete esg history, request access »

Belluscura Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
TMT Acquisition (Special Purpose Acquisition Company (SPAC)) London, United Kingdom 2021

Belluscura FAQs

  • When was Belluscura founded?

    Belluscura was founded in 2015.

  • Where is Belluscura headquartered?

    Belluscura is headquartered in London, United Kingdom.

  • What is the size of Belluscura?

    Belluscura has 22 total employees.

  • What industry is Belluscura in?

    Belluscura’s primary industry is Therapeutic Devices.

  • Is Belluscura a private or public company?

    Belluscura is a Private company.

  • What is Belluscura’s current revenue?

    The current revenue for Belluscura is .

  • How much funding has Belluscura raised over time?

    Belluscura has raised $47.2M.

  • Who are Belluscura’s investors?

    Tekcapital and Cardiff University have invested in Belluscura.

  • Who are Belluscura’s competitors?

    Inogen, CAIRE (Georgia), and Philips are competitors of Belluscura.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process